The Impact of Vitamin D3Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease
Open Access
- 4 May 2015
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-12
Abstract
Intracellular calcium concentration in peripheral blood mononuclear cells (PBMCs) of patients with chronic kidney disease (CKD) is significantly increased, and the regulatory mechanisms maintaining cellular calcium homeostasis are impaired. The purpose of this study was to examine the effect of vitaminon predominant regulatory mechanisms of cell calcium homeostasis. The study involved 16 CKD stages 2-3 patients with vitamin D deficiency treated with cholecalciferol 7000–14000 IU/week for 6 months. The regulatory mechanisms of calcium signaling were studied in PBMCs and red blood cells. After vitaminsupplementation, serum concentration of 25(OH)increased () anddecreased (). The differences inwere inversely related to differences in 25(OH)concentration (). Vitaminsupplementation decreased the calcium entry through calcium release activated calcium (CRAC) channels and purinergic P2X7channels. The function of P2X7receptors was changed in comparison with their baseline status, and the expression of these receptors was reduced. There was no effect of vitaminon P2X7pores and activity of plasma membrane Ca2+-ATPases. Vitaminsupplementation had a beneficial effect ondecreasing calcium entry via CRAC and P2X7channels and reducing P2X7receptors expression.
Keywords
Funding Information
- Center of Excellence of Environmental Health (26240120033)
This publication has 48 references indexed in Scilit:
- STIM1-dependent store-operated Ca2+ entry is required for pathological cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2012
- Adipocyte P2X7 receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome?Atherosclerosis, 2011
- Immunodeficiency due to mutations in ORAI1 and STIM1Clinical Immunology, 2010
- Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca2+ entry via STIM proteinsCell Calcium, 2010
- ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasiaJournal of Allergy and Clinical Immunology, 2009
- STIM1Mutation Associated with a Syndrome of Immunodeficiency and AutoimmunityNew England Journal of Medicine, 2009
- Evidence for STIM1‐ and Orail‐dependent storeoperated calcium influx through I CRAC in vascular smooth muscle cells: role in proliferation and migrationThe FASEB Journal, 2009
- Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca2+responses to hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Characterization of a selective and potent antagonist of human P2X7receptors, AZ11645373British Journal of Pharmacology, 2006
- Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosisClinical and Experimental Immunology, 2006